STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

RXRX (NASDAQ: RXRX) holder Christopher Gibson plans 100,000-share sale after prior disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RXRX shareholder Christopher C. Gibson filed to sell 100,000 Class A shares through Fidelity Brokerage Services LLC, with an aggregate market value of $296,725.90 and identifier 524677865, on NASDAQ as of 07/17/2026. The shares derive from Founders Shares originally issued on 04/20/2021 as compensation.

The filing also lists extensive Class A share sales in the prior three months by Gibson, the Gibson Family Trust, and Lahwran-3 LLC, including individual transactions such as 340,440 shares for $1,089,541.29 on 06/18/2026 and multiple 100,000‑share sales on various July 2026 dates.

Positive

  • None.

Negative

  • None.
Proposed shares to be sold 100000 shares Class A shares proposed for sale through Fidelity Brokerage Services LLC
Proposed sale value $296,725.90 Aggregate market value for 100,000 Class A shares associated with identifier 524677865
Identifier 524677865 Identifier listed for the Class A securities on NASDAQ
Sale on 06/18/2026 340,440 shares for $1,089,541.29 Class A sale by Christopher C. Gibson disclosed as prior three‑month transaction
Sale on 07/01/2026 100,000 shares for $366,630.37 Class A sale by Christopher C. Gibson listed among recent sales
Gibson Family Trust sale 07/07/2026 50,000 shares for $195,014.41 Class A sale by Gibson Family Trust
Lahwran-3 LLC sale 07/09/2026 186,000 shares for $706,094.96 Class A sale by Lahwran-3 LLC within prior three months
Founders Shares financial
"Class A | 04/20/2021 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Compensation financial
"100000 | 04/20/2021 | Compensation"
Gibson Family Trust financial
"Gibson Family Trust 41 S Rio Grande Street Salt Lake City UT 84101"
Lahwran-3 Llc financial
"Lahwran-3 Llc 41 S Rio Grande Street Salt Lake City UT 84101"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does the RXRX Form 144 filing by Christopher C. Gibson report?
The filing reports a planned sale of 100,000 Class A shares of RXRX through Fidelity Brokerage Services LLC, with an aggregate market value of $296,725.90, and discloses multiple prior Class A share sales over the preceding three months.

How many RXRX shares does Christopher C. Gibson plan to sell under this Form 144?
He plans to sell 100,000 Class A shares of RXRX. These are held at Fidelity Brokerage Services LLC and are associated with identifier 524677865, with an indicated aggregate market value of $296,725.90 as of the NASDAQ reference date 07/17/2026.

What is the origin of the RXRX shares covered by this Form 144 notice?
The shares are identified as Founders Shares issued on 04/20/2021 by the issuer to Christopher C. Gibson as compensation. The filing connects this compensation issuance to the 100,000 Class A shares now proposed for resale.

What past RXRX stock sales are disclosed for Christopher C. Gibson in the last three months?
The filing lists several Class A sales by Gibson, including 40,000 shares for $144,400.00 on 04/22/2026 and multiple 100,000‑share sales in July 2026, each with specified aggregate prices such as $366,630.37 and $378,604.31.

On which market and under what identifier are the RXRX shares in this Form 144 referenced?
The Class A shares are referenced as trading on NASDAQ and are associated with the identifier 524677865. The proposed 100,000‑share sale through Fidelity carries an aggregate market value of $296,725.90 tied to this identifier and market.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR